Kathleen Egan
Overview
Explore the profile of Kathleen Egan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marley G, Annis I, Ostrach B, Egan K, Delamater P, Bell R, et al.
J Am Pharm Assoc (2003)
. 2024 Feb;
64(3):102021.
PMID: 38307248
Background: According to a standing order in North Carolina (NC), naloxone can be purchased without a provider prescription. Objective: The objective of this study is to examine whether same-day naloxone...
2.
Baumer N, Becker M, Capone G, Egan K, Fortea J, Handen B, et al.
J Neurodev Disord
. 2022 Mar;
14(1):22.
PMID: 35321660
The recent National Institute of Health (NIH) INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) initiative has bolstered capacity for the current increase in clinical trials...
3.
Yaghjyan L, Colditz G, Rosner B, Rich S, Egan K, Tamimi R
Eur J Nutr
. 2019 Jun;
59(4):1633-1639.
PMID: 31152213
Purpose: Previous studies suggest that coffee and caffeine intake may be associated with reduced breast cancer risk. To date, there is limited and inconsistent epidemiologic evidence for associations of adolescent...
4.
de Leede N, Bastiaannet E, van der Geest L, Egan K, van de Velde C, Balducci L, et al.
J Geriatr Oncol
. 2019 Feb;
10(4):584-590.
PMID: 30799177
Objectives: A significant proportion of patients with pancreatic cancer are over the age of 70 years. The aim was to compare treatment and survival for older patients with pancreatic cancer...
5.
Zeng C, Guo X, Long J, Kuchenbaecker K, Droit A, Michailidou K, et al.
Breast Cancer Res
. 2016 Jul;
18(1):64.
PMID: 27459855
Background: Multiple recent genome-wide association studies (GWAS) have identified a single nucleotide polymorphism (SNP), rs10771399, at 12p11 that is associated with breast cancer risk. Method: We performed a fine-scale mapping...
6.
Kirsh K, Heit H, Huskey A, Strickland J, Egan K, Passik S
J Opioid Manag
. 2015 Mar;
11(1):61-8.
PMID: 25750166
Objective: Urine drug testing (UDT) can play an important role in the care of patients in recovery from addiction, and it has become necessary for providers and programs to utilize...
7.
Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess P, et al.
J Clin Trials
. 2014 Feb;
2(1).
PMID: 24533253
In spite of the large number of nutrient-derived agents demonstrating promise as potential chemopreventive agents, most have failed to prove effectiveness in clinical trials. Critical requirements for moving nutrient-derived agents...
8.
Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, et al.
PLoS Genet
. 2013 Apr;
9(3):e1003284.
PMID: 23544014
Various common genetic susceptibility loci have been identified for breast cancer; however, it is unclear how they combine with lifestyle/environmental risk factors to influence risk. We undertook an international collaborative...
9.
Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess P, Egan K, et al.
Contemp Clin Trials
. 2011 Nov;
33(2):279-85.
PMID: 22101219
Objective: The goal of this report is to describe the on going strategies, successes, challenges and solutions for recruitment in this multi-center, phase II chemoprevention trial targeting men at high...
10.
Figueroa J, Garcia-Closas M, Humphreys M, Platte R, Hopper J, Southey M, et al.
Hum Mol Genet
. 2011 Aug;
20(23):4693-706.
PMID: 21852249
A genome-wide association study (GWAS) identified single-nucleotide polymorphisms (SNPs) at 1p11.2 and 14q24.1 (RAD51L1) as breast cancer susceptibility loci. The initial GWAS suggested stronger effects for both loci for estrogen...